STRS Ohio’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-33,300
| Closed | -$722K | – | 2024 |
|
|
2017
Q2 | $722K | Sell |
33,300
-16,200
| -33% | -$294K | ﹤0.01% | 1064 |
|
|
2017
Q1 | $694K | Buy |
49,500
+21,800
| +79% | +$357K | ﹤0.01% | 1103 |
|
|
2016
Q4 | $519K | Sell |
27,700
-14,900
| -35% | -$253K | ﹤0.01% | 1334 |
|
|
2016
Q3 | $703K | Sell |
42,600
-4,800
| -10% | -$71.1K | ﹤0.01% | 1047 |
|
|
2016
Q2 | $637K | Buy |
47,400
+11,500
| +32% | +$168K | ﹤0.01% | 1137 |
|
|
2016
Q1 | $548K | Hold |
35,900
| – | – | ﹤0.01% | 1220 |
|
|
2015
Q4 | $712K | Sell |
35,900
-2,100
| -6% | -$39.9K | ﹤0.01% | 1026 |
|
|
2015
Q3 | $661K | Sell |
38,000
-800
| -2% | -$16.3K | ﹤0.01% | 1092 |
|
|
2015
Q2 | $784K | Sell |
38,800
-3,800
| -9% | -$73.3K | ﹤0.01% | 1044 |
|
|
2015
Q1 | $749K | Sell |
42,600
-6,300
| -13% | -$107K | ﹤0.01% | 983 |
|
|
2014
Q4 | $796K | Buy |
48,900
+15,300
| +46% | +$281K | ﹤0.01% | 931 |
|
|
2014
Q3 | $742K | Sell |
33,600
-4,600
| -12% | -$94.2K | ﹤0.01% | 912 |
|
|
2014
Q2 | $769K | Sell |
38,200
-4,100
| -10% | -$69.4K | ﹤0.01% | 959 |
|
|
2014
Q1 | $786K | Sell |
42,300
-28,800
| -41% | -$397K | ﹤0.01% | 881 |
|
|
2013
Q4 | $717K | Buy |
71,100
+5,100
| +8% | +$61.6K | ﹤0.01% | 1007 |
|
|
2013
Q3 | $851K | Sell |
66,000
-2,300
| -3% | -$28.3K | ﹤0.01% | 945 |
|
|
2013
Q2 | $811K | Buy |
+68,300
| New | +$740K | ﹤0.01% | 1016 |
|
Other funds holding AMRI
STRS Ohio's AMRI Position: Q3 2017 in Review
STRS Ohio sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 33,300 shares — an estimated $722K sold.
STRS Ohio first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $851K in Q3 2013. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.
- STRS Ohio reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
- STRS Ohio sold 33,300 Albany Molecular Research Inc shares in Q3 2017, an estimated $722K.
- STRS Ohio first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
- STRS Ohio's Albany Molecular Research Inc position peaked at $851K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.
Based on STRS Ohio's 13F filing for Q3 2017, filed 23 Oct 2017.